Literature DB >> 32064154

BIRC7 promotes epithelial-mesenchymal transition and metastasis in papillary thyroid carcinoma through restraining autophagy.

Kunpeng Liu1,2, Qingan Yu3,2, Hao Li3, Changming Xie3, Yaohua Wu3, Dakun Ma3, Ping Sheng1,2, Wenjie Dai3,2, Hongchi Jiang1,2.   

Abstract

Papillary thyroid carcinoma (PTC) is the most common cancer of the endocrine system, which is usually associated with a favorable therapeutic response and prognosis. However, metastatic spreading occurs in around 5% of the PTC patients. Identification of molecular markers could early predict the metastatic potential, which is essential for reducing the patient's overtreatment. Baculoviral IAP Repeat Containing 7 (BIRC7) is an inhibitor of apoptosis protein (IAP) family gene that is known to be linked to tumor progression, but its role in the setting of PTC metastasis remains unknown. This study, therefore, aims to explore the role of BIRC7 in the metastasis and autophagy of PTC and elucidate its underlying molecular mechanisms. BIRC7 expression was assessed in fresh samples of human PTC and normal tissues via qRT-PCR and immunohistochemistry. In addition, BIRC7 was overexpressed and silenced in PTC cell lines followed by transmission electron microscopy, western blotting, immunofluorescence microscopy, wound healing and invasion assays. We further explored the relevance of BIRC7 in vivo using a tumor xenograft model. Our results demonstrated that BIRC7 plays a pro-invasive role in PTC. BIRC7 expression is significantly upregulated in PTC compared with matched thyroid normal tissues. In addition, we found that BIRC7 knockdown induced a significant reduction in PTC cell EMT and metastasis in vitro and in vivo, while overexpression of BIRC7 markedly enhanced PTC cell migration and invasion. Moreover, our data showed that BIRC7 was able to suppress autophagy through modulating the expression of ATG5 and BECN1, and that this suppression is responsible for BIRC7 silence induced suppression of EMT and metastasis of PTC cell. We further found that targeting both BIRC7 and mTOR enhances autophagy in PTC cells and to achieve synergistic antimetastatic efficacy in vitro and in vivo. These findings indicate that the suppression of autophagy by BIRC7 drives the invasion and metastasis of PTC cells, thus suggesting that the activation of autophagy may inhibit metastasis of PTC with high BIRC7 expression. AJCR
Copyright © 2020.

Entities:  

Keywords:  BIRC7; EMT; autophagy; metastasis; papillary thyroid carcinoma

Year:  2020        PMID: 32064154      PMCID: PMC7017743     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  7 in total

1.  Cystatin SN promotes epithelial-mesenchymal transition and serves as a prognostic biomarker in lung adenocarcinoma.

Authors:  Jian Yang; Gaomeng Luo; Chang Li; Zhunlin Zhao; Sheng Ju; Qifan Li; Zhike Chen; Cheng Ding; Xin Tong; Jun Zhao
Journal:  BMC Cancer       Date:  2022-05-30       Impact factor: 4.638

2.  A seven-autophagy-related gene signature for predicting the prognosis of differentiated thyroid carcinoma.

Authors:  Chengxin Li; Qianqian Yuan; Gaoran Xu; Qian Yang; Jinxuan Hou; Lewei Zheng; Gaosong Wu
Journal:  World J Surg Oncol       Date:  2022-04-23       Impact factor: 3.253

3.  Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin.

Authors:  Mohammed Faruk; Sani Ibrahim; Surajo Mohammed Aminu; Ahmed Adamu; Adamu Abdullahi; Aishatu Maude Suleiman; Abdulmumini Hassan Rafindadi; Abdullahi Mohammed; Yawale Iliyasu; John Idoko; Rakiya Saidu; Abdullahi Jibril Randawa; Halimatu Sadiya Musa; Atara Ntekim; Khalid Zahir Shah; Sani Abubakar; Kasimu Umar Adoke; Muhammad Manko; Cheh Agustin Awasum
Journal:  PLoS One       Date:  2021-01-19       Impact factor: 3.240

Review 4.  Targeting Autophagy in Thyroid Cancer: EMT, Apoptosis, and Cancer Stem Cells.

Authors:  Tammy M Holm; Syn Yeo; Kevin M Turner; Jun-Lin Guan
Journal:  Front Cell Dev Biol       Date:  2022-06-29

5.  Parkinson's Disease Phenotypes in Patient Neuronal Cultures and Brain Organoids Improved by 2-Hydroxypropyl-β-Cyclodextrin Treatment.

Authors:  Javier Jarazo; Kyriaki Barmpa; Jennifer Modamio; Cláudia Saraiva; Sònia Sabaté-Soler; Isabel Rosety; Anne Griesbeck; Florian Skwirblies; Gaia Zaffaroni; Lisa M Smits; Jihui Su; Jonathan Arias-Fuenzalida; Jonas Walter; Gemma Gomez-Giro; Anna S Monzel; Xiaobing Qing; Armelle Vitali; Gerald Cruciani; Ibrahim Boussaad; Francesco Brunelli; Christian Jäger; Aleksandar Rakovic; Wen Li; Lin Yuan; Emanuel Berger; Giuseppe Arena; Silvia Bolognin; Ronny Schmidt; Christoph Schröder; Paul M A Antony; Christine Klein; Rejko Krüger; Philip Seibler; Jens C Schwamborn
Journal:  Mov Disord       Date:  2021-10-12       Impact factor: 9.698

6.  Oncogenic Role of miR-217 During Clear Cell Renal Carcinoma Progression.

Authors:  Jose María Zamora-Fuentes; Enrique Hernández-Lemus; Jesús Espinal-Enríquez
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

7.  Livin/BIRC7 gene expression as a possible diagnostic biomarker for endometrial hyperplasia and carcinoma.

Authors:  Basma K Elmekkawy; Rasha M S Shoaib; Amal K Seleem; Dalia Shaalan; Entsar A Saad
Journal:  J Genet Eng Biotechnol       Date:  2021-09-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.